# MedisourceRx – FDA Inspection, Sep 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/medisourcerx/edce067b-34b5-461a-893a-58fbf6a61073
Source feed: FDA_Inspections

> FDA inspection 1067011 of MedisourceRx, September 27, 2018. 7 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067011
- Company Name: MedisourceRx
- Inspection Date: 2018-09-27
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1272492 - 2025-06-10](https://www.keypedia.com/records/fda_inspections/medisourcerx/5e1c7664-e512-4a49-832f-44a69404210a)
- FDA Inspection 1191700 - 2022-11-04
- [FDA Inspection 1131719 - 2020-10-22](https://www.keypedia.com/records/fda_inspections/medisourcerx/a41be081-b03d-43cf-bdf8-7b6507777311)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)
- [Stephanie A. Slater](https://www.keypedia.com/people/stephanie-a-slater/f356e65c-3398-4688-8b86-4dcd4b9ae83b)

Company: https://www.keypedia.com/companies/medisourcerx/9a855143-6076-4b52-a4e0-94d0d179a448

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b